RET-IN-34

Overview

RET-IN-34 is a RET inhibitor with an IC 50 of 0.89 nM. RET-IN-34 serves as a target protein ligand for PROTAC synthesis ( Ligand for Target Protein for PROTAC ). RET-IN-34 is applicable for the synthesis of PROTAC RET Degrader 2 ( HY-183783 ). RET-IN-34 exhibits anticancer activity against medullary thyroid carcinoma. RET-IN-34 can be used in studies related to medullary thyroid carcinoma.

Application

Products | Products > Disease Areas > Cancer | Products > Disease Areas > Metabolic or Endocrine Disease | Products > Disease Areas > Thyroid Cancer | Products > Disease Areas > Thyroid Disease | Products > Signaling Pathways > PROTAC | Products > Signaling Pathways > Protein Tyrosine Kinase/RTK | Products > Research Areas > Endocrinology | Products > Research Areas > Cancer | Products > Research Areas > Cancer > Cancer Targeted Therapy | Products > Signaling Pathways > Ligands for Target Protein for PROTAC | Products > Signaling Pathways > RET

Product Information

• Catalog No.: HY-183729
• CAS No.: 2222758-09-8
• Molecular Formula: C31H34N8O2
• Molecular Weight: 550.65
• Storage: Please store the product under the recommended conditions in the Certificate of Analysis.

Source

Original product source